Logo image of AEVA

AEVA TECHNOLOGIES INC (AEVA) Stock Fundamental Analysis

NASDAQ:AEVA - US00835Q2021 - Common Stock

14.99 USD
+0.94 (+6.69%)
Last: 8/26/2025, 8:14:04 PM
15.19 USD
+0.2 (+1.33%)
Pre-Market: 8/27/2025, 4:16:51 AM
Fundamental Rating

2

Taking everything into account, AEVA scores 2 out of 10 in our fundamental rating. AEVA was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. AEVA may be in some trouble as it scores bad on both profitability and health. AEVA is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

AEVA had negative earnings in the past year.
In the past year AEVA has reported a negative cash flow from operations.
In the past 5 years AEVA always reported negative net income.
AEVA had a negative operating cash flow in each of the past 5 years.
AEVA Yearly Net Income VS EBIT VS OCF VS FCFAEVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

AEVA has a Return On Assets of -330.39%. This is amonst the worse of the industry: AEVA underperforms 99.19% of its industry peers.
Industry RankSector Rank
ROA -330.39%
ROE N/A
ROIC N/A
ROA(3y)-67.52%
ROA(5y)-60.44%
ROE(3y)-87.76%
ROE(5y)-76.12%
ROIC(3y)N/A
ROIC(5y)N/A
AEVA Yearly ROA, ROE, ROICAEVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

AEVA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AEVA Yearly Profit, Operating, Gross MarginsAEVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

0

2. Health

2.1 Basic Checks

AEVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AEVA has been increased compared to 1 year ago.
AEVA has more shares outstanding than it did 5 years ago.
There is no outstanding debt for AEVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AEVA Yearly Shares OutstandingAEVA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
AEVA Yearly Total Debt VS Total AssetsAEVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

AEVA has an Altman-Z score of -15.79. This is a bad value and indicates that AEVA is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -15.79, AEVA is not doing good in the industry: 95.16% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -15.79
ROIC/WACCN/A
WACC9.53%
AEVA Yearly LT Debt VS Equity VS FCFAEVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 0.65 indicates that AEVA may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.65, AEVA is doing worse than 95.97% of the companies in the same industry.
AEVA has a Quick Ratio of 0.65. This is a bad value and indicates that AEVA is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.61, AEVA is doing worse than 92.74% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.65
Quick Ratio 0.61
AEVA Yearly Current Assets VS Current LiabilitesAEVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 30.58% over the past year.
Looking at the last year, AEVA shows a very strong growth in Revenue. The Revenue has grown by 111.39%.
The Revenue has been growing by 45.63% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)30.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.81%
Revenue 1Y (TTM)111.39%
Revenue growth 3Y-0.72%
Revenue growth 5Y45.63%
Sales Q2Q%173.91%

3.2 Future

Based on estimates for the next years, AEVA will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.35% on average per year.
AEVA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 119.40% yearly.
EPS Next Y14.92%
EPS Next 2Y8.55%
EPS Next 3Y7.03%
EPS Next 5Y15.35%
Revenue Next Year111.41%
Revenue Next 2Y103.67%
Revenue Next 3Y115.13%
Revenue Next 5Y119.4%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AEVA Yearly Revenue VS EstimatesAEVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
AEVA Yearly EPS VS EstimatesAEVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 -2 -3

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AEVA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AEVA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AEVA Price Earnings VS Forward Price EarningsAEVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AEVA Per share dataAEVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.55%
EPS Next 3Y7.03%

0

5. Dividend

5.1 Amount

AEVA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AEVA TECHNOLOGIES INC

NASDAQ:AEVA (8/26/2025, 8:14:04 PM)

Premarket: 15.19 +0.2 (+1.33%)

14.99

+0.94 (+6.69%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners56.48%
Inst Owner Change17.66%
Ins Owners31.84%
Ins Owner Change39.42%
Market Cap844.39M
Analysts81.82
Price Target26.72 (78.25%)
Short Float %22.68%
Short Ratio2.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.46%
Min EPS beat(2)7.43%
Max EPS beat(2)13.49%
EPS beat(4)4
Avg EPS beat(4)11.51%
Min EPS beat(4)7.43%
Max EPS beat(4)16.82%
EPS beat(8)7
Avg EPS beat(8)4.49%
EPS beat(12)9
Avg EPS beat(12)2.75%
EPS beat(16)10
Avg EPS beat(16)-0.71%
Revenue beat(2)2
Avg Revenue beat(2)50.37%
Min Revenue beat(2)41.51%
Max Revenue beat(2)59.23%
Revenue beat(4)4
Avg Revenue beat(4)28.24%
Min Revenue beat(4)5.04%
Max Revenue beat(4)59.23%
Revenue beat(8)7
Avg Revenue beat(8)19.31%
Revenue beat(12)9
Avg Revenue beat(12)5.27%
Revenue beat(16)12
Avg Revenue beat(16)4.29%
PT rev (1m)21.3%
PT rev (3m)299.7%
EPS NQ rev (1m)-5.38%
EPS NQ rev (3m)1.05%
EPS NY rev (1m)-0.78%
EPS NY rev (3m)5.53%
Revenue NQ rev (1m)13.28%
Revenue NQ rev (3m)10.34%
Revenue NY rev (1m)8.02%
Revenue NY rev (3m)16.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 61.08
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.93
EYN/A
EPS(NY)-1.78
Fwd EYN/A
FCF(TTM)-1.99
FCFYN/A
OCF(TTM)-1.91
OCFYN/A
SpS0.25
BVpS-2.1
TBVpS-2.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -330.39%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-67.52%
ROA(5y)-60.44%
ROE(3y)-87.76%
ROE(5y)-76.12%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 41.91%
Cap/Sales 32.59%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.65
Quick Ratio 0.61
Altman-Z -15.79
F-Score4
WACC9.53%
ROIC/WACCN/A
Cap/Depr(3y)139%
Cap/Depr(5y)250.43%
Cap/Sales(3y)125.12%
Cap/Sales(5y)96.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.81%
EPS Next Y14.92%
EPS Next 2Y8.55%
EPS Next 3Y7.03%
EPS Next 5Y15.35%
Revenue 1Y (TTM)111.39%
Revenue growth 3Y-0.72%
Revenue growth 5Y45.63%
Sales Q2Q%173.91%
Revenue Next Year111.41%
Revenue Next 2Y103.67%
Revenue Next 3Y115.13%
Revenue Next 5Y119.4%
EBIT growth 1Y6.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year22.59%
EBIT Next 3Y7.14%
EBIT Next 5Y11.44%
FCF growth 1Y7.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.9%
OCF growth 3YN/A
OCF growth 5YN/A